Skip to content

Are cranberry capsules useful in preventing urinary tract infection in hip fracture patients with urinary tract catheter

Are cranberry capsules useful in preventing urinary tract infection in hip fracture patients with urinary tract catheter

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
EU CTR
Registry ID
EUCTR2008-002390-13-SE
Enrollment
Unknown
Registered
2008-10-22
Start date
2009-04-08
Completion date
Unknown
Last updated
2013-11-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Urinary tract infections in patients with hip fractures. MedDRA version: 9.1 Level: LLT Classification code 10046571 Term: Urinary tract infection

Interventions

Trade Name: Daily Wellness Tranbär Product Name: Daily Wellness Tranbär Pharmaceutical Form: Capsule, hard Concentration unit: % percent Concentration type: range Concentration number: 0.8-1.5 Pharmac

Sponsors

University Hospital
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. Patients admitted to the University hosptial with hip fracture 2. Woman 3. Older than 60 years 4. Patients with an signed informed consent form Are the trial subjects under 18? no Number of subjects for this age range: F.1.2 Adults (18-64 years) yes F.1.2.1 Number of subjects for this age range F.1.3 Elderly (>=65 years) yes F.1.3.1 Number of subjects for this age range

Exclusion criteria

Exclusion criteria: 1. Permanent urinary tracht catheter 2. Medication with Warfarin 4. Kidney disease with prescribed protein reduced diet or a maximum limit of liquid intake or dialysis treatment 5. Serious liver disease or high alcohol intake 6. Symptoms of on-going urinary tract infection 7. Antibiotic treatment at admission

Design outcomes

Primary

MeasureTime frame
Main Objective: To investigate if cranberry capsules can decrease the incidense of bacteriuria in hip fracture patients with a peroperative urinary tract catheter ;Secondary Objective: Is there a difference in time to first urinary tract infection between the cranberry- and placebo treated groups? Are there any differences in the urinary tract catheter biofilm between the cranberry- and placebo groups? Is there a difference in IL-6 levels in the urine of cranberry- and placebo treated patients? ;Primary end point(s): Prevalence of bacterias in the urine.

Countries

Sweden

Outcome results

None listed

Source: EU CTR (via WHO ICTRP) · Data processed: Feb 4, 2026